Questcor Pharmaceuticals (NASDAQ:QCOR)
A pharmaceutical company that focuses on novel therapeutics for the treatment of diseases and disorders of the central nervous system.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
Recs
getrichdietrying
(72.08)
Submitted: 6/15/2013 6:15:49 PM :
Start Price:
$46.38
QCOR Score:
-1.85
shorts under pressure
Recs
manirg
(39.06)
Submitted: 6/14/2013 1:19:58 PM :
Start Price:
$46.01
QCOR Score:
-1.81
very undervalued
Recs
pchop123
(76.64)
Submitted: 5/23/2013 2:05:03 PM :
Start Price:
$35.18
QCOR Score:
+30.43
rebound in near future
Recs
Recs
Litigation
(24.57)
Submitted: 3/16/2013 7:17:12 PM :
Start Price:
$31.62
QCOR Score:
+37.87
Price Target: $46
Recs
penikajt
(< 20)
Submitted: 3/10/2013 10:34:58 AM :
Start Price:
$31.11
QCOR Score:
+40.96
This company provides one of the best drugs to treat MS. Additionally, it has strong cashflow, balance sheet, margins, and sales growth. They are actively seeking to expand both the uses of its current mainstay drug, and to enter other areas of drug treatment. The market overly punished this stock on bad news. Look for continued revenue growth funding new products.
Recs
EpikurFool
(62.86)
Submitted: 3/9/2013 4:14:25 AM :
Start Price:
$30.60
QCOR Score:
+40.70
yes, this company had some problems in the past (Aetna announced that it would restrict coverage of the leading product Acthar Gel). However the figures still encourage to take an outperformance view: Forward PE of 6, PEG 0.35. Very high ROE, Gross Margin and Oper. Margin.
Recs
NechesInvst
(99.50)
Submitted: 3/6/2013 1:48:42 PM :
Start Price:
$29.54
QCOR Score:
+48.20
In hopes that the government investigation won't amount to much, and looking at a drug company with no debt and two drugs on the market...I'm hopeful for the best. Target: 65-80 price 3 to 4 years out.
Recs
Kidkerner
(74.88)
Submitted: 3/6/2013 3:10:49 AM :
Start Price:
$30.60
QCOR Score:
+43.06
Unjustifiably beaten down, trading 50% below 52-week high. Proven track record of beating on EPS and revenue. 30% projected 5-year growth rate. This is a $60 stock.
Recs
chris293
(55.08)
Submitted: 2/18/2013 1:48:01 AM :
Start Price:
$29.63
QCOR Score:
+46.25
A lot of companies are the same 'drug' thing?
Recs
foolishbk
(< 20)
Submitted: 2/16/2013 10:56:56 PM :
Start Price:
$29.63
QCOR Score:
+46.25
I'm thinking that the bears are going to get tired of paying the dividends, and the lawyers will get tired of chasing the ambulances they are trolling for the stockholder suits.
Recs
BobbyWMiller
(70.06)
Submitted: 1/29/2013 5:46:48 AM :
Start Price:
$25.38
QCOR Score:
+70.34
I adore herd mentality. It made Buffett more money than any human deserves and has proved me it at least one 30 day cruise a year now for twelve years as well the money to crisscross the U.S. in my RV without spending one dime of my retirement check or taking one our of my money market accounts. The herd ran from QCOR like school children running from a snake and ran to DDD like it was a bunny rabbit. Bless you, herd.
"Time is the friend of the wonderful company, the enemy of the mediocre." - Warren Buffett
Recs
physdude
(48.59)
Submitted: 1/25/2013 4:05:36 AM :
Start Price:
$25.22
QCOR Score:
+71.60
It is being pushed down by false rumors and will recover once their effect is over.
Recs
10cent
(97.16)
Submitted: 1/11/2013 8:17:34 PM :
Start Price:
$25.56
QCOR Score:
+66.84
High short interest. Speculation.
Recs
MarkP28665
(39.21)
Submitted: 1/9/2013 7:20:10 PM :
Start Price:
$26.27
QCOR Score:
+61.90
Appears to have a good pipeline and is currently profitable.
Recs
healthcarevalue
(97.64)
Submitted: 1/9/2013 4:43:19 PM :
Start Price:
$26.27
QCOR Score:
+61.90
QCOR. Questcor Pharmaceuticals. Extremely impressive return on invested capital ROIC of greater than 100 percent for last twelve trailing months. Price earnings ratio is low at 10.23. Financial health is good, debt/equity ratio is quite low with value of nil per morningstar.com data. Market cap of 1.55 billion leaves room to grow and/or be acquired.
Recs
Hugerat
(24.23)
Submitted: 12/31/2012 9:10:16 AM :
Start Price:
$26.21
QCOR Score:
-56.58
Just another company run by con men and plagued with nepotism.
Recs
BuffettJunior1
(97.61)
Submitted: 12/6/2012 11:12:47 PM :
Start Price:
$26.02
QCOR Score:
-60.24
http://www.citronresearch.com/questcor-update-re-primethera/
Recs
kulls81
(< 20)
Submitted: 11/29/2012 1:07:43 PM :
Start Price:
$27.94
QCOR Score:
+47.61
Magic Formula 11-29-12
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 71 : 1 2 3 4 Next »